Abstract:
Basic competencies in assessing and treating substance use disorders should be core to the training of any clinical psychologist, because of the high frequency of risky or problematic substance use in the community, and its high co-occurrence with other problems. Skills in establishing trust and a therapeutic alliance are particularly important in addiction, given the stigma and potential for legal sanctions that surround it. The knowledge and skills of all clinical practitioners should be sufficient to allow valid screening and diagnosis of substance use disorders, accurate estimation of consumption and a basic functional analysis. Practitioners should also be able to undertake brief interventions including motivational interviews, and appropriately apply generic interventions such as problem solving or goal setting to addiction. Furthermore, clinical psychologists should have an understanding of the nature, evidence base and indications for biochemical assays, pharmacotherapies and other medical treatments, and ways these can be integrated with psychological practice.
Specialists in addiction should have more sophisticated competencies in each of these areas. They need to have a detailed understating of current addiction theories and basic and applied research, be able to undertake and report on a detailed psychological assessment, and display expert competence in addiction treatment. These skills should include an ability to assess and manage complex or co-occurring problems, to adapt interventions to the needs of different groups, and to assist people who have not responded to basic treatments. They should also be able to provide consultation to others, undertake evaluations of their practice, and monitor and evaluate emerging research data in the field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allen, J. P. & Wilson, V. B. (2003). Assessing alcohol problems: A guide for clinicians and researchers (2nd ed.). Bethesda, MD: NIAAA.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
Anonymous. (2007). How alcoholics anonymous works. Harvard Mental Health Letter, 24(1), 4–6.
Armstrong, T. D. & Costello, E. J. (2002). Commu-nity studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. Jour-nal of Consulting and Clinical Psychology, 70, 1224–1239.
Assanangkornchai, S. & Srisurapanont, M. (2007). The treatment of alcohol dependence. Current Opinion in Psychiatry, 20, 222–227.
Azrin, N. H. (1976). Improvements in the community-reinforcement approach to alcoholism. Behaviour Research and Therapy, 14, 339–348.
Babor, T. F. & Kadden, R. M. (2005). Screening and interventions for alcohol and drug problems in medical settings: What works? The Journal of Trauma, 59(Suppl. 3), 80–87.
Bala, M. V. & Lesniak, W. (2007). Efficacy of non-pharmacological methods used for treating tobacco dependence: Meta-analysis. Polskie Archiwum Medycyny Wewnetrznej, 117, 504–511.
Baldwin, A. R., Oei, T. P. S., & Young, R. M. (1993). To drink or not to drink: The differential role of alcohol expectancies and drinking refusal self-efficacy in quantity and frequency of alcohol consumption. Cognitive Therapy and Research, 17, 511–530.
Bandura, A. (1982). Self-efficacy mechanisms in human agency. American Psychologist, 37, 122–147.
Bandura, A. (1997). Self-efficacy: The exercise of control. New York: Freeman.
Bandura, A. (1999). A sociocognitive analysis of substance abuse: An agentic perspective. Psychological Science, 10, 214–217.
Beck, A. T. (1993). Cognitive therapy: Nature and relation to behavior therapy. Journal of Psychotherapy Practice and Research, 2, 345–356.
Berglund, M., Thelander, S., Salaspuro, M., Franck, J., Andreasson, S., & Ojehagen, A. (2003). Treatment of alcohol abuse: An evidence-based review. Alcoholism: Clinical and Experimental Research, 27, 1645–1656.
Bouza, C., Magro, A., Munoz, A., & Amate, J. M. (2004). Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: A systematic review. Addiction, 99, 811–828.
Burke, B. L., Arkowitz, H., & Menchola, M. (2003). The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials. Journal of Consulting and Clinical Psychology, 71, 843–861.
Bush, D. M., Autry, J. H., 3rd, Bush, D. M., & Autry, J. H., 3rd. (2002). Substance abuse in the workplace: epidemiology, effects, and industry response. Occupational Medicine, 17, 13–25.
Cahill, K., Stead, L. F., & Lancaster, T. (2008). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, (3), DOI: 10.1002/14651858.CD006103.pub3.
Carroll, K. M., Easton, C. J., Nich, C., Hunkele, K. A., Neavins, T. M., Sinha, R. et al. (2006). The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. Journal of Consulting and Clinical Psychology, 74, 955–966.
Carroll, K. M., Nich, C., & Ball, S. A. (2005). Practice makes progress? Homework assignments and outcome in treatment of cocaine dependence. Journal of Consulting and Clinical Psychology, 73, 749–755.
Carter, B. L. & Tiffany, S. T. (1999). Meta-analysis of cue-reactivity in addiction research. Addiction, 94, 327–340.
Chick, J. (1999). Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Safety, 20, 427–435.
Connor, J. P., Saunders, J. B., & Feeney, G. F. X. (2006). Quality of life in addiction. In Katschnig, H., Freeman, H., & Sartorius, N. (Eds.), Quality of life in mental disorders (pp. 199–208). New York: Wiley.
Cournoyer, L. G., Brochu, S., Landry, M., & Bergeron, J. (2007). Therapeutic alliance, patient behaviour and dropout in a drug rehabilitation programme: The moderating effect of clinical subpopulations. Addiction, 102, 1960–1970.
Dawe, S., Loxton, N. J., Hides, L., Kavanagh, D. J., & Mattick, R. P. (2002). Review of diagnostic screening instruments for alcohol and other drug use and other psychiatric conditions (2nd ed.). Canberra: Commonwealth Department of Health and Ageing.
Dawe, S., Rees, V. W., Mattick, R., Sitharthan, T., & Heather, N. (2002). Efficacy of moderation-oriented cue exposure for problem drinkers: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 70, 1045–1050.
Deci, E. L., Koestner, R., & Ryan, R. M. (1999). A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychological Bulletin, 125, 627–688.
Denis, C., Lavie, E., Fatseas, M., & Auriacombe, M. (2006). Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database of Systematic Reviews, (3), DOI: 10.1002/14651858.CD005336.pub2.
Devos-Comby, L. & Lange, J. E. (2008). “My drink is larger than yours”? A literature review of self-defined drink sizes and standard drinks. Current Drug Abuse Reviews, 1, 162–176.
Drummond, D. C. & Glautier, S. (1994). A controlled trial of cue exposure treatment in alcohol dependence. Journal of Consulting and Clinical Psychology, 62, 809–817.
Dunn, C., Deroo, L., & Rivara, F. P. (2001). The use of brief interventions adapted from motivational interviewing across behavioral domains: A systematic review. Addiction, 96, 1725–1742.
Edwards, G. & Gross, M. M. (1976). Alcohol dependence: Provisional description of a clinical syndrome. British Medical Journal, 1, 1058–1061.
Emrick, C. (2001). Alcoholics anonymous and other mutual aid groups. In Heather, N., Peters, T. J., & Stockwell, T. (Eds.), International handbook of alcohol dependence and problems. New York: Wiley.
Feeney, G. F., Connor, J. P., Young, R. M., Tucker, J., & McPherson, A. (2006). Combined acamprosate and naltrexone with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: A single centres’ experience with pharmacotherapy. Alcohol and Alcoholism, 41, 321–327.
Feingold, A. & Rounsaville, B. (1995). Construct validity of the abuse-dependence distinction as measured by DSM-IV criteria for different psychoactive substances. Drug and Alcohol Dependence, 39, 99–109.
Ferri, M. M. F., Amato, L., & Davoli, M. (2006). Alcoholics anonymous and other 12-step programmes for alcohol dependence. Cochrane Database of Systematic Reviews, (3), DOI: 10.1002/14651858.CD005032.pub2.
Fillmore, K., Kerr, W., Stockwell, T., & Bostrom, T. C. A. (2006). Moderate alcohol use and reduced mortality risk: Systematic error in prospective studies. Addiction Research and Theory, 14, 101–132.
Forys, K., McKellar, J., & Moos, R. (2007). Participation in specific treatment components predicts alcohol-specific and general coping skills. Addictive Behaviors, 32, 1669–1680.
Foxcroft, D., Ireland, D., Lowe, F., & Breen, R. (2002). Primary prevention for alcohol misuse in young people. Cochrane Database of Systematic Reviews, (3), DOI: 10.1002/14651858.CD003024.
Frishman, W. H., Del Vecchio, A., Sanal, S., & Ismail, A. (2003). Cardiovascular manifestations of substance abuse part 1: Cocaine. Heart Disease, 5, 187–201.
Fuller, R. K. & Gordis, E. (2004). Does disulfiram have a role in alcoholism treatment today? Addiction, 99, 21–24.
Gillespie, N. A., Neale, M. C., Prescott, C. A., Aggen, S. H., & Kendler, K. S. (2007). Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids. Addiction, 102, 920–930.
Goldman, M. S., Brown, S. A., & Christiansen, B. A. (1987). Expectancy theory: Thinking about drinking. In Blane, H. T. & Leonard, K. E. (Eds.), Psychological theories of drinking and alcoholism (pp. 181–226). New York: Guilford.
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W. et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on alcohol and related conditions. Archives of General Psychiatry, 61, 807–816.
Green, B., Kavanagh, D. J., & Young, R. M. (2003). Being stoned: A review of self-reported cannabis effects. Drug and Alcohol Review, 22, 453–460.
Hardt, F. (1992). Antabuse treatment for excessive users of alcohol. Acta Psychiatrica Scandinavica Supplementum, 369, 37–40.
Helig, M. & Egli, M. (2006). Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms. Pharmacology & Therapeutics, 111, 855–876.
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007). Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, (1), DOI: 10.1002/14651858.CD000031.pub3.
Hunt, G. M. & Azrin, N. H. (1973). A community-reinforcement approach to alcoholism. Behaviour Research and Therapy, 11, 91–104.
Jelski, W. & Szmitkowski, M. (2008). Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases. Clinica Chimica Acta, 395, 1–5.
Kahler, C. W. & Strong, D. R. (2006). A rasch model analysis of DSM-IV alcohol abuse and dependence items in the national epidemiological survey on alcohol and related conditions. Alcoholism: Clinical & Experimental Research, 30, 1165–1175.
Kaner, E. F. S., Dickinson, H. O., Beyer, F. R., Campbell, F., Schlesinger, C., Heather, N. et al. (2007). Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database of Systematic Reviews, (2), DOI: 10.1002/14651858.CD004148.pub3.
Kavanagh, D. J., Andrade, J., & May, J. (2004). Beating the urge: Implications of research into substance-related desires. Addictive Behaviors, 29, 1359–1372.
Kavanagh, D. J., & Connolly, J. (2009a). Assessment of co-occurring addictive and other mental disorders. In Miller, P. M. (Ed.), Evidence-based addiction treatment. (pp. 89–117). San Diego: Elsevier.
Kavanagh, D. J., & Connolly, J. M. (2009b). Interventions for co-occurring addictive and other mental disorders (AMDs). Addictive Behaviors, doi:10.1016/j.addbeh.2009.03.005.
Kavanagh, D. J., Sitharthan, T., & Sayer, G. P. (1996). Prediction of results from correspondence treatment for controlled drinking. Addiction, 91, 1539–1545.
Kavanagh, D. J., Sitharthan, T., Spilsbury, G., & Vignaendra, S. (1999). An evaluation of brief correspondence programs for problem drinkers. Behavior Therapy, 30(4), 641–656.
Kavanagh, D. J., Sitharthan, G., Young, R. M., Sitharthan, T., Saunders, J. B., Shockley, N. et al. (2006). Addition of cue exposure to cognitive-behavior therapy for alcohol misuse: A randomized trial with dysphoric drinkers. Addiction, 101, 1106–1116.
Kavanagh, D. J., Spence, S. H., Strong, J., Wilson, J., Sturk, H., & Crow, N. (2003). Supervision practices in allied mental health: A staff survey. Mental Health Services Research, 5, 187–195.
Kavanagh, D. J., Spence, S. H., Wilson, J., & Crow, N. (2002). Achieving effective supervision. Drug and Alcohol Review, 21, 247–252.
Kazdin, A. E. (2006). Mediators and mechanisms of change in psychotherapy research. Annual Review of Clinical Psychology, 3, 1–27.
Kelly, J. F. (2003). Self-help for substance-use disord-ers: History, effectiveness, knowledge gaps, and research opportunities. Clinical Psychology Review, 23, 639–663.
Kessler, R. C., McGonagle, K. A., Zhao, S., & Nelson, C. B. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the national comorbidity survey. Archives of General Psychiatry, 51, 8–19.
Knapp, W. P., Soares, B., Farrell, M., & Silva de Lima, M. (2007). Psychosocial interventions for cocaine and psychostimulant amphetamine related disorders. Cochrane Database of Systematic Reviews, (3), DOI: 10.1002/14651858.CD003023.pub2.
Koob, G. F. & Le Moal, M. (2008). Review: Neurobiological mechanisms for opponent motivational processes in addiction. Philosophical Transactions of the Royal Society of London – Series B: Biological Sciences, 363, 3113–3123.
Kownacki, R. J. & Shadish, W. R. (1999). Does alcoholics anonymous work? The results from a meta-analysis of controlled experiments. Substance Use and Misuse, 34, 1897–1916.
Kranzler, H. R. & Van Kirk, J. (2001). Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis. Alcoholism: Clinical and Experimental Research, 25, 1335–1341.
Lee, N. K. & Rawson, R. A. (2008). A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug and Alcohol Review, 27, 309–317.
Li, T. K. (2008). Quantifying the risk for alcohol-use and alcohol-attributable health disorders: Present findings and future research needs. Journal of Gastroenterology and Hepatology, 23(Suppl. 1), 2–8.
Litt, M. D., Kadden, R. M., Cooney, N. L., & Kabela, E. (2003). Coping skills and treatment outcomes in cognitive-behavioral and interactional group therapy for alcoholism. Journal of Consulting and Clinical Psychology, 71, 118–128.
Long, C. G., Williams, M., Midgley, M., & Hollin, C. R. (2000). Within-program factors as predictors of drinking outcome following cognitive-behavioral treatment. Addictive Behaviors, 25, 573–578.
Longabaugh, R. (2007). The search for mechanisms of change in behavioral treatments for alcohol use disorders: A commentary. Alcoholism: Clinical and Experimental Research, 31(Suppl. 3), 21–32.
Longabaugh, R., Donovan, D. M., Karno, M. P., McCrady, B. S., Morgenstern, J., & Tonigan, J. S. (2005). Active ingredients: How and why evidence-based alcohol behavioral treatment interventions work. Alcoholism: Clinical and Experimental Research, 29, 235–247.
Longabaugh, R., Wirtz, P. W., Zweben, A., & Stout, R. L. (1998). Network support for drinking, alcoholics anonymous and long-term matching effects. Addiction, 93, 1313–1333.
MacAndrew, C. & Edgerton, R. B. (1969). Drunken comportment: A social explanation. Chicago, IL: Aldine.
Maisto, S. A., Connors, G. J., & Zywiak, W. H. (2000). Alcohol treatment, changes in coping skills, self-efficacy, and levels of alcohol use and related problems 1 year following treatment initiation. Psychology of Addictive Behaviors, 14, 257–266.
Malcolm, R., Olive, M. F., & Lechner, W. (2008). The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: Guidance for clinical practice. Expert Opinion on Drug Safety, 7, 459–472.
Marlatt, G. A. & Rohsenow, D. J. (1980). Cognitive processes in alcohol use: Expectancy and the balanced place-bo design. In Mello, N. K. (Ed.), Advances in substance abuse, vol. 1 (pp. 159–199). Greenwich, UK: JAI.
Mattick, R. P., Breen, C., Kimber, J., Davoli, M., & Breen, R. (2003). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, (2), DOI: 10.1002/14651858.CD002209.
Mayet, S., Farrell, M., Ferri, M. M. F., Amato, L., & Davoli, M. P. (2004). Psychosocial treatment for opiate abuse and dependence. Cochrane Database of Systematic Reviews, (4), DOI: 10.1002/14651858.CD004330.pub2.
McKay, J. R., Maisto, S. A., & O’Farrell, T. J. (1993). End-of-treatment self-efficacy, aftercare, and drinking outcomes of alcoholic men. Alcoholism: Clinical and Experimental Research, 17, 1078–1083.
McKellar, J. D., Harris, A. H., & Moos, R. H. (2006). Predictors of outcome for patients with substance-use disorders five years after treatment dropout. Journal of Studies on Alcohol, 67, 685–693.
McKellar, J. D., Ilgen, M., Moos, B. S., & Moos, R. H. (2008). Predictors of changes in alcohol-related self-efficacy over 16 years. Journal of Substance Abuse Treatment, 35, 148–155.
Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S. et al. (1998). Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology. Addictive Behaviors, 23, 893–907.
Meyers, R. J., Miller, W. R., Hill, D. E., & Tonigan, J. S. (1998). Community reinforcement and family training (CRAFT): Engaging unmotivated drug users in treatment. Journal of Substance Abuse, 10, 291–308.
Miller, P. M. & Anton, R. F. (2004). Biochemical screening in primary care. Addictive Behaviors, 29, 1427–1437.
Miller, W. R. (1983). Motivational interviewing with problem drinkers. Behavioural Psychotherapy, 11, 147–172.
Miller, W. R. & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York: Guilford.
Miller, W. R. & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (2nd ed.). New York: Guilford.
Miller, W. R. & Wilbourne, P. L. (2002). Mesa Grande: A methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction, 97, 265–277.
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. (2006). Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database of Systematic Reviews, (1), DOI: 10.1002/14651858.CD001333.pub2.
Monti, P. M., Rohsenow, D. J., Rubonis, A. V., Niaura, R. S., Sirota, A. D., Colby, S. M. et al. (1993). Cue exposure with coping skills treatment for male alcoholics: A preliminary investigation. Journal of Consulting and Clinical Psychology, 61, 1011–1019.
Moos, R. H. (2007). Theory-based processes that promote the remission of substance use disorders. Clinical Psychology Review, 27, 537–551.
Moos, R. H. (2008). Active ingredients of substance use-focused self-help groups. Addiction, 103, 387–396.
Morgenstern, J. & Longabaugh, R. (2000). Cognitive-behavioral treatment for alcohol dependence: A review of evidence for its hypothesized mechanisms of action. Addiction, 95, 1475–1490.
Morgenstern, J. & McKay, J. R. (2007). Rethinkingthe paradigms that inform behavioral treatment research for substance use disorders. Addiction, 102, 1377–1389.
Musshoff, F. & Madea, B. (2006). Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Therapeutic Drug Monitoring, 28, 155–163.
O’Farrell, T. J. & Fals-Stewart, W. (2002). Behavioral couples and family therapy for substance abusers. Current Psychiatry Reports, 4, 371–376.
Parr, J. M., Kavanagh, D. J., Cahill, L., Mitchell, G., & Young, R. M. (2009). Effectiveness of current treatment approaches for benzodiazepine discontinuation: A meta-analysis. Addiction, 104, 13–24.
Petry, N. M., Peirce, J. M., Stitzer, M. L., Blaine, J., Roll, J. M., Cohen, A. et al. (2005). Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment clinical trials network study. Archives of General Psychiatry, 62, 1148–1156.
Pettinati, H. M., O’Brien, C. P., Rabinowitz, A. R., Wortman, S. P., Oslin, D. W., Kampman, K. M. et al. (2006). The status of naltrexone in the treatment of alcohol dependence: Specific effects on heavy drinking. Journal of Clinical Psychopharmacology, 26, 610–625.
Powers, M. B., Vedel, E., & Emmelkamp, P. M. G. (2008). Behavioral couples therapy (BCT) for alcohol and drug use disorders: A meta-analysis. Clinical Psychology Review, 28, 952–962.
Pre, J. & Vassy, R. (1992). Plasma thiocyanate and cigarette-smoking status. Medical Science Research, 20, 671–672.
Prochaska, J. O. & DiClemente, C. C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51, 390–395.
Project MATCH Research Group. (1997). Project MATCH secondary a priori hypotheses. Addiction, 92, 1671–1698.
Project MATCH Research Group. (1998). Matching alcoholism treatments to client heterogeneity: Pro-ject MATCH three year drinking outcomes. Alcoholism: Clinical and Experimental Research, 22, 1300–1311.
Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L. et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. Journal of the American Medical Association, 264, 2511–2518.
Robinson, T. E. & Berridge, K. C. (1993). The neural basis of craving: An incentive-sensitization theory of addiction. Brain Research Reviews, 18, 247–291.
Roese, N. J. & Jamieson, D. W. (1993). Twenty years of bogus pipeline research: A critical review and meta-analysis. Psychological Bulletin, 114, 363–375.
Rollnick, S. & Miller, W. R. (1995). What is motivational interviewing? Behavioural and Cognitive Psychotherapy, 23, 325–334.
Roozen, H. G., Boulogne, J. J., van Tulder, M. W., van den Brink, W., De Jong, C. A. J., & Kerkhof, A. J. F. M. (2004). A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug and Alcohol Dependence, 74, 1–13.
Rubak, S., Sandback, A., Lauritzen, T., & Christensen, B. (2005). Motivational interviewing: A systematic review and meta-analysis. British Journal of General Practice, 55, 305–312.
Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., & Grant, M. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction, 88, 791–804.
Secades-Villa, R., Garcia-Rodriguez, O., Higgins, S. T., Fernandez-Hermida, J. R., & Carballo, J. L. (2008). Community reinforcement approach plus vouchers for cocaine dependence in a community setting in Spain: Six-month outcomes. Journal of Substance Abuse Treatment, 34, 202–207.
Sitharthan, T., Sitharthan, G., Hough, M. J., & Kavanagh, D. J. (1997). Cue exposure in moderation drinking: A comparison with cognitive-behavior therapy. Journal of Consulting and Clinical Psychology, 65, 878–882.
Skutle, A. (1999). The relationship among self-efficacy expectancies, severity of alcohol abuse, and psychological benefits from drinking. Addictive Behaviors, 24, 87–98.
Smith, J. E., Meyers, R. J., & Miller, W. R. (2001). The community reinforcement approach to the treatment of substance use disorders. American Journal on Addictions, 10(Suppl. 1), 51–59.
Sobell, L. C. & Sobell, M. B. (1992). Timeline followback: A technique for assessing self-reported alcohol consumption. In Litten, R. Z. & Allen, J. P. (Eds.), Measuring alcohol consumption: Psychosocial and biochemical methods (pp. 41–72). Totowa, NJ: Humana.
Sobell, M. B. & Sobell, L. C. (1993). Problem drinkers: Guided self-change treatment. New York: Guilford.
Solomon, K. E. & Annis, H. M. (1990). Outcome and efficacy expectancy in the prediction of post-treatment drinking behaviour. British Journal of Addiction, 85, 659–665.
Solomon, R. L. (1980). The opponent-process theory of acquired motivation: The costs of pleasure and the benefits of pain. American Psychologist, 35, 691–712.
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews, (1), DOI: 10.1002/14651858.CD000146.pub3.
Stein, M. D., Solomon, D. A., Herman, D. S., Anthony, J. L., Ramsey, S. E., Anderson, B. J. et al. (2004). Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. Archives of General Psychiatry, 61, 152–159.
Stitzer, M. & Petry, N. (2006). Contingency management for treatment of substance abuse. Annual Review of Clinical Psychology, 2, 411–434.
Stockwell, T., Gruenewald, P. J., Toumbourou, J. W., & Loxley, W. (2005). Preventing harmful substance use: The evidence base for policy and practice. New York: Wiley.
Stockwell, T., Hodgson, R., Edwards, G., Taylor, C., & Rankin, M. (1979). The development of a questionnaire to measure severity of alcohol dependence. British Journal of Addiction, 74, 79–87.
Substance Abuse and Mental Health Services Administration. (2008). Results from the 2007 national survey on drug use and health: National findings (Office of Applied Studies, NSDUH Series H-34, DHHS Publication No. SMA 08–4343). Rockville, MD.
Tate, J. C. & Schmitz, J. M. (1993). A proposed revision of the Fagerstrom tolerance questionnaire. Addictive Behaviors, 18, 135–143.
The Clinical Practice Guideline Treating Tobacco Use and Dependence Update Panel Liaisons and Staff. (2008). A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. American Journal of Preventive Medicine, 35, 158–176.
Uhart, M. & Wand, G. S. (2009). Stress, alcohol and drug interaction: An update of human research. Addiction Biology, 14, 43–64.
UKATT Research Team. (2005). Effectiveness of treatment for alcohol problems: Findings of the randomised UK alcohol treatment trial (UKATT). British Medical Journal, 331, 541–544.
UKATT Research Team. (2008). UK alcohol treatment trial- client treatment matching effects. Addiction, 103, 228–238.
United States Department of Agriculture and United States Department of Health and Human Services. (2005). Dietary guidelines for Americans (6th ed.). Washington, DC: US Government Printing Office.
Vaillant, G. E. (2005). Alcoholics anonymous: Cult or cure? Australian and New Zealand Journal of Psychiatry, 39, 431–436.
Vasilaki, E. I., Hosier, S. G., & Cox, W. M. (2006). The efficacy of motivational interviewing as a brief intervention for excessive drinking: A meta-analytic review. Alcohol and Alcoholism, 41, 328–335.
Walton, M. A., Blow, F. C., Bingham, C. R., & Chermack, S. T. (2003). Individual and social/environmental predictors of alcohol and drug use 2 years following substance abuse treatment. Addictive Behaviors, 28, 627–642.
Weinberg, N. Z., Rahdert, E., Colliver, J. D., & Glantz, M. D. (1998). Adolescent substance abuse: A re-view of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 252–261.
White, D. & Pitts, M. (1998). Educating young peo-ple about drugs: A systematic review. Addiction, 93, 1475–1487.
Wilson, P. H., Spence, S. H., & Kavanagh, D. J. (1989). Cognitive behavioural interviewing for adult disorders. London: Routledge.
Wong, C. C., Schumann, G., Wong, C. C. Y., & Schumann, G. (2008). Review. Genetics of addictions: strategies for addressing heterogeneity and polygenicity of substance use disorders. Philosophical Transactions of the Royal Society of London – Series B: Biological Sciences, 363(1507), 3213–3222.
World Health Organization. (2004). ICD-10: International statistical classification of diseases and related health problems; Tenth revision (2nd ed.). Geneva, Switzerland: World Health Organization.
World Health Organization. (2008). The global burden of disease: 2004 update. Geneva, Switzerland: WHO.
Young, R. M., Lawford, B. R., Nutting, A., & Noble, E. P. (2004). Advances in molecular genetics and the prevention and treatment of substance misuse: Impli-cations of asso-ciation studies of the A1 allele of the D2 dopamine receptor gene. Addictive Behaviors, 29, 1275–1294.
Young, R. M. & Oei, T. P. S. (1993). Grape expectations: The role of alcohol expectancies in the understanding and treatment of problem drinking. International Journal of Psychology, 28, 337–364.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Kavanagh, D.J., Connor, J., Young, R. (2010). Substance Use Disorders. In: Thomas, J.C., Hersen, M. (eds) Handbook of Clinical Psychology Competencies. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09757-2_32
Download citation
DOI: https://doi.org/10.1007/978-0-387-09757-2_32
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-09756-5
Online ISBN: 978-0-387-09757-2
eBook Packages: Behavioral Science